News
Relief for AZ, Amgen as FDA okays severe asthma hope tezepel...
The FDA has approved AstraZeneca and Amgen's severe asthma hope tezepelumab, exonerating the drugmakers' decision to press ahead with a regulatory filing despite a failed phase 3 trial.
